Intermittent prednisolone and autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis.
Aberg
L
L
Pediatric Neurology, University of Helsinki, Helsinki, Finland. laura.aberg@fimnet.fi
Talling
M
M
Härkönen
T
T
Lönnqvist
T
T
Knip
M
M
Alen
R
R
Rantala
H
H
Tyynelä
J
J
D000293:Adolescent; D000367:Age Factors; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D001921:Brain / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006801:Humans; D007360:Intelligence / Q000187:drug effects / Q000502:physiology; D008297:Male; D009069:Movement Disorders / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D009472:Neuronal Ceroid-Lipofuscinoses / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D011239:Prednisolone / Q000008:administration & dosage*; D020127:Recovery of Function / Q000187:drug effects / Q000276:immunology; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000096:biosynthesis
D001323:Autoantibodies; D015415:Biomarkers; D005938:Glucocorticoids; D005680:gamma-Aminobutyric Acid; D011239:Prednisolone; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2